Category - Pharma Industry News
Jazz Pharma’s blood cancer therapy Rylaze wins US approval
MHRA authorises Diurnal’s CAH therapy Efmody
AZ says MPO inhibitor AZD4831 shows promise in heart failure study
Elliott Management puts pressure on GSK after years of ‘disappointing performance’
Cambridge University scientists identify 160 new drugs with COVID-19 repurposing potential
ICER says price of Biogen’s Aduhelm should be much lower
Final data shows CureVac’s COVID-19 vaccine is only 48% effective
Rinvoq scores positive results as a maintenance therapy for ulcerative colitis